Long-Term Follow-Up and Outcome of Liver Transplantation From Anti-Hepatitis C Virus-Positive Donors: A European Multicentric Case-Control Study
- 15 June 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 91 (11), 1265-1272
- https://doi.org/10.1097/tp.0b013e318219eb8f
Abstract
Background. The growing prevalence of hepatitis C virus (HCV) infection in the general population has resulted in an increased frequency of potential organ donors that carry the virus. Given the significant disparity between organ supply and demand for transplantation, it becomes essential to consider whether livers from anti-HCV-positive donors may be considered suitable for transplantation. Methods. Based on a multicenter European database, 694 patients with HCV-related cirrhosis underwent liver transplantation and 11% of them received the graft from anti-HCV-positive donors. Of this group, we selected 63 patients (study group) and, after a 1:1 case-control approach, compared them with 63 patients that received an anti-HCV-negative donor graft (control group). Only grafts with preperfusion liver biopsy results with a fibrosis score of not more than 1 were used for transplantation. Results. Patients who received anti-HCV-positive grafts had a cumulative survival rate of 83.6% and 61.7% at 1 and 5 years, respectively, vs. 95.1% and 68.2% for the control group. In comparing overall patient and graft survival, there was no statistically significant difference between the two groups (P = 0.22 and 0.11). Recurrence of hepatitis C tended to be more rapid in the group of patients who received anti-HCV-positive grafts, although it did not reach statistical significance (P = 0.07). Conclusions. We do not recommend the indiscriminate use of anti-HCV-positive donors, especially if HCV-RNA positive, as the use of this kind of graft could be linked to an advanced stage of fibrosis, the main risk factor we observed for earlier hepatitis C recurrenceKeywords
This publication has 32 references indexed in Scilit:
- Is there disease progression in patients who are hepatitis C virus antibody-positive and hepatitis C virus RNA-seronegative?Hepatology, 2008
- Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allograftsLiver Transplantation, 2006
- Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: A decision analysisLiver Transplantation, 2004
- Fibrosis progression after liver transplantation in patients with recurrent hepatitis CJournal of Hepatology, 2004
- Living donor liver transplantationJournal of Hepatology, 2003
- Liver transplantation with hepatitis C virus-infected graft: Interaction between donor and recipient viral strainsHepatology, 2003
- Recurrent and new hepatitis C virus infection after liver transplantationHepatology, 1999
- EASL International Consensus Conference on Hepatitis CParis, 26–27 February 1999Consensus StatementJournal of Hepatology, 1999
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- One Thousand Liver Transplants The Lessons LearnedAnnals of Surgery, 1994